SARMs (Selective Androgen Receptor Modulators)
SARMs (Selective Androgen Receptor Modulators) — Non-steroidal compounds that selectively bind androgen receptors in specific tissues, studied alongside peptides in muscle and bone biology research.
What Are SARMs?
Selective androgen receptor modulators (SARMs) are non-steroidal compounds that selectively activate androgen receptors in muscle and bone while minimizing effects on prostate and other tissues. While SARMs are not peptides, they are frequently discussed alongside peptide GH secretagogues in research contexts due to overlapping interest in muscle and performance research.
Distinction from Peptides
- Mechanism: SARMs bind nuclear androgen receptor (direct). Peptide GHS stimulate endogenous hormone release (indirect)
- Route: SARMs are orally bioavailable small molecules. Most research peptides require injection
- Regulation: SARMs are not FDA-approved for any indication. Investigational research compounds only
Frequently Asked Questions
What is SARMs (Selective Androgen Receptor Modulators)?
Non-steroidal compounds that selectively bind androgen receptors in specific tissues, studied alongside peptides in muscle and bone biology research.
Why is SARMs (Selective Androgen Receptor Modulators) important in peptide research?
SARMs (Selective Androgen Receptor Modulators) is a fundamental concept in compound as it relates to peptide science. It directly influences experimental design, compound characterization, and the reliability of research outcomes across biochemistry and molecular biology disciplines.
Authority Sources
- SARMs (Selective Androgen Receptor Modulators) on Wikipedia
- Search SARMs (Selective Androgen Receptor Modulators) on PubChem (NIH)
- Research articles on ScienceDirect